Two distinct roads to the same damaged joint

An old ankle sprain that never quite settled is, in many cases, the starting point for ankle arthritis — and that link is far more direct than most patients realise. Around 90% of ankle osteoarthritis traces back to prior trauma, compared with just 2–10% of knee OA cases. The ankle, in other words, is a fundamentally different joint when it comes to how arthritis begins.

Two distinct roads lead there. In post-sprain OA (PSOA), damage accumulates quietly over years — sometimes decades — as repeated instability episodes gradually erode the joint surface. In post-fracture OA (PFOA), the trigger is a single high-energy event: the fracture itself sets off an immediate inflammatory cascade that begins degrading cartilage from the moment of injury.

These are not interchangeable labels. Each pathway carries a different conservation window — the period during which intervention can slow or redirect the damage — along with a different latency, a different pattern on imaging, and a different prognosis at the point of surgery.

Underpinning both is a structural vulnerability the knee does not share: ankle cartilage is roughly half the thickness of knee cartilage, concentrating greater force per unit area. It is one reason ankle OA patients are typically diagnosed around 14 years younger than people with OA elsewhere in the body.

The cartilage cascade in recurrent sprains

Every ankle sprain inflicts more than ligament damage. At the moment of injury — even a relatively mild one — the articular surface can absorb a direct blow or sustain a small fracture of the joint surface, initiating localised cartilage damage before any instability has had time to develop. Animal model research illustrates just how little force this requires: a grade I sprain producing partial laxity of the calcaneofibular or deltoid ligament was sufficient to trigger histologically confirmed post-traumatic cartilage changes within 12 weeks, challenging the long-held assumption that minor sprains are clinically trivial.

The second mechanism is slower, but compounds relentlessly over time. Once laxity persists and chronic lateral ankle instability (CAI) becomes established, the joint no longer moves as a congruent unit. Abnormal excursion during every step shifts load asymmetrically, bearing down disproportionately on the medial talar dome — the region least designed to absorb it. The result is what some researchers describe as an incremental 'cartilage cascade': micro-injuries accumulating across repeated loading cycles, each one adding fractionally to the erosion of a surface already compromised by earlier sprain events.

The cumulative picture in humans with CAI is striking. A 2022 meta-analysis found that 32% of people with established instability carry a concurrent osteochondral or chondral lesion; of talar lesions identified, 68% are located on the medial dome — precisely where abnormal loading concentrates. MRI T2 mapping can detect compositional changes in cartilage before anything appears abnormal on a standard X-ray, meaning structural damage may be quietly progressing through what looks, radiographically, like an unremarkable joint.

The average time between a first sprain and the clinical onset of arthritis is approximately 21 years. That latency is long enough that patients — and sometimes clinicians — underestimate the stakes. It is, however, finite, and the micro-injuries accumulating during it are not always reversible once a threshold has been crossed.

Why post-fracture arthritis follows a different course

Fracture-driven arthritis operates on an entirely different clock. Where sprain damage accumulates over years of repeated loading, a malleolar fracture compresses the entire damaging sequence into a single moment: articular congruity is disrupted immediately, bone is often comminuted, and — within hours — the synovial fluid fills with a chemical environment of joint-destructive signals. IL-1β, TNF-α, and matrix metalloproteinases are released acutely, beginning to degrade cartilage matrix before any healing has taken hold.

This post-fracture molecular environment is not simply an accelerated version of the sprain pathway. Bulk RNA-sequencing of synovial tissue can distinguish early post-fracture synovium from end-stage post-traumatic OA and from end-stage non-traumatic OA as three separate biological states — confirming that the inflammatory signature of a fresh fracture represents a distinct disease process, not a point on a shared spectrum.

The clinical consequence is a 20-year OA risk of approximately 40% after malleolar fracture, with the highest rates following bimalleolar Weber B/C injuries and fractures involving the posterior tibial rim.

That biological distinction has real consequences at the operating table. Patients with PFOA show significantly smaller pre-to-postoperative gains in ankle joint power and ankle joint work during gait after total ankle arthroplasty, compared with patients whose arthritis followed a sprain-based course. The fracture pathway appears to create a deeper biomechanical deficit — one that even a well-executed joint replacement cannot fully reverse — which makes pre-operative counselling for PFOA patients meaningfully different from the conversation held with someone on the sprain-to-arthritis trajectory.

What the conservation window actually looks like

For many patients, the most pressing question is not how damage accumulates — but whether it has already accumulated too far to matter. The conservation window offers a more useful frame: a clinically identifiable period during which the ankle's mechanical situation has deteriorated, but the cartilage surface has not yet crossed into irreversible structural loss.

The best available tool for locating a patient within that window is MRI T2 mapping — a scan that measures the water content and collagen organisation within cartilage rather than simply its surface contour. Because it picks up compositional changes before visible surface breakdown, T2 mapping can reveal that cartilage is already under metabolic stress in people with chronic instability whose standard imaging looks unremarkable. A normal plain radiograph, in this context, is not reassurance; it is a characteristic feature of early-window disease, not evidence that the joint is unaffected.

The window itself appears prolonged — the roughly 21-year average latency between first sprain and clinical arthritis, noted earlier, reflects that — but its closing is neither gradual nor clearly signposted. No study has yet defined a threshold number of sprain episodes at which cartilage damage becomes irreversible. That absence of a defined tipping point cuts both ways: it prevents false precision about when to act, but it equally means there is no safe floor for inaction.

What the evidence does suggest is that once structural cartilage loss begins, it tends to progress to end-stage disease faster in the ankle than in other joints. That asymmetry makes earlier intervention — while the window is still open and detectable on T2 imaging — disproportionately more valuable than waiting for symptoms to force the issue.

Conservative and biological strategies while the window is open

Restoring mechanical stability is the single highest-priority intervention during the conservation window, and the starting point is neuromuscular physiotherapy. Targeted rehabilitation corrects the aberrant joint loading that drives the cartilage cascade, rebuilding proprioceptive control and reducing the abnormal contact stresses concentrated on the medial talar dome in chronic instability. Ankle bracing provides an external limit on pathological joint excursion, complementing what muscles alone may not yet reliably achieve. Weight management carries its own mechanical logic: each additional pound of body weight imposes roughly four pounds of load across the ankle joint, making even modest reductions clinically meaningful.

For osteochondral injuries identified during this phase, protected weight-bearing in a walking boot — alongside activity modification, NSAIDs for inflammatory flares, and physiotherapy — resolves approximately 50% of acute, non-displaced talar lesions without further intervention.

A counterintuitive finding from a 2025 randomised controlled trial is worth foregrounding here. In patients with chronic lateral ankle instability carrying small talar osteochondral lesions under 150 mm², adding microfracture to lateral ligament reconstruction produced no mid-term clinical benefit over reconstruction alone — and significantly delayed recovery at three months. The practical implication is important: restoring joint stability may itself be sufficient to arrest early cartilage progression, and adding a cartilage procedure does not necessarily improve on that foundation.

When conservative measures plateau, injectable biological options enter the picture as adjuncts — not replacements for the mechanical work done by physiotherapy and bracing. Intra-articular hyaluronic acid and PRP have been used in this setting; the evidence across OA populations suggests modest symptomatic benefit, though data specific to sprain-based ankle OA remain limited, with most trials drawing from knee cohorts. Collagen-based injectable scaffolds, such as ChondroFiller injection — an ultrasound-guided outpatient treatment that places an acellular matrix into the defect to support the joint's biological environment — represent an emerging tier within this category, and PSOA-specific trial data for these options are equally still developing. A specialist assessment is needed to determine which adjunct, if any, is appropriate at a given stage of disease.

When to get a specialist opinion

Three presentations justify moving beyond GP or physio-led care without delay. Recurrent sprains that continue to give way despite a sustained course of physiotherapy suggest instability has outgrown what soft-tissue rehabilitation alone can correct. Ankle pain or swelling that has not settled within six to eight weeks of appropriate conservative management warrants review before the conservation window narrows further. And any history of ankle fracture — particularly bimalleolar or posterior rim injury — paired with new or worsening symptoms should prompt specialist assessment regardless of how much time has passed; that pathway can remain quiet for years before accelerating.

A specialist assessment typically combines history, examination, and weight-bearing radiographs; where cartilage concern accompanies instability, MRI with T2 mapping adds compositional information that standard imaging misses in the early-window phase. As discussed earlier, a normal-looking plain radiograph is a characteristic feature of conservation-window disease, not reassurance of a healthy joint. Asking whether T2 mapping is offered is a reasonable question to raise at referral.

Patients presenting with both chronic instability and cartilage symptoms benefit most from a clinician who can evaluate both components together — the two interact, and a pathway addressing only one tends to underperform.

The London Cartilage Clinic on Harley Street offers specialist assessment and, where appropriate, ultrasound-guided outpatient treatment for ankle cartilage lesions, including ChondroFiller injection for suitable cases. Appointments can be arranged at londoncartilage.com.

1. [1] Effects of chronic ankle instability after grade I ankle sprain on the post-traumatic osteoarthritis. (2024). https://doi.org/10.1186/s13075-024-03402-w https://doi.org/10.1186/s13075-024-03402-w
2. [2] Evaluation of Open Versus Arthroscopic Anterior Talofibular Ligament Reconstruction for Chronic Lateral Ankle Instability With Talar and Subtalar Cartilage MRI T2 Mapping. (2024). https://doi.org/10.1177/03635465231222931 https://doi.org/10.1177/03635465231222931
3. [3] One in Three Patients With Chronic Lateral Ankle Instability Has a Cartilage Lesion. (2022). https://doi.org/10.1177/03635465221084365 https://doi.org/10.1177/03635465221084365